Forbes Medi-Tech Inc. has completed the previously announced sale of substantially all of its assets to Pharmachem Laboratories, Inc. for $4 million. In connection with the completion of the sale, the company has changed its name to FMI Holdings Ltd.

Shareholders also approved the liquidation of the company and the appointment of Abakhan & Associates Inc. as liquidator. The company currently anticipates that Abakhan will be formally appointed as liquidator on or about September 1.

In connection with the wind-up of the company, one distribution will be made to shareholders, which will include the cash proceeds realized under the asset sale less any payments made in respect of the company’s remaining ongoing costs and liabilities. The company expects the net proceeds of the liquidation to be in the range of Cdn $0.50 to Cdn $0.58 per share.

The distribution is expected to occur within six months following completion of a claims procedure that will be established under the supervision of the appointed liquidator, Abakhan & Associates Inc. It is expected that, following the distribution, the company’s common shares will be cancelled and de-listed from the OTCBB.

It is anticipated that the wind-up of the company will be completed in the first quarter of 2011, although the ultimate timing of a distribution and the wind-up of the company may vary from what is expected.

In addition, to the extent that, among other things: (i) transaction and wind-up costs; (ii) the company’s net cash position at closing; (iii) the absence of unidentified claims; or (iv) foreign exchange rates are, in each case, different than assumptions made by management, shareholders may receive aggregate distributions amounting to less than the range noted. Accordingly, the company can give no assurances as to the total amount and timing of distributions to the company’s shareholders.